APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical and Biopharmaceutical Safety Testing Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Growth and Trends Forecast to 2032

12 August 2026122 pages

Choose your research edition.

Industry ResearchPharmaceutical and Biopharmaceutical Safety Testing Service Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

According to APO Research, the global Pharmaceutical and Biopharmaceutical Safety Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pharmaceutical and Biopharmaceutical Safety Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical and Biopharmaceutical Safety Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical and Biopharmaceutical Safety Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Pharmaceutical and Biopharmaceutical Safety Testing Service market include Eurofins Scientific, SGS, Q2 Solutions, Samsung Biologics, Texcell, WuXi Biologics, Wuhan Canvest Biotechnology, Centre Testing International (CTI) and Suzhou Liangchen Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pharmaceutical and Biopharmaceutical Safety Testing Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pharmaceutical and Biopharmaceutical Safety Testing Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharmaceutical and Biopharmaceutical Safety Testing Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharmaceutical and Biopharmaceutical Safety Testing Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Pharmaceutical and Biopharmaceutical Safety Testing Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pharmaceutical and Biopharmaceutical Safety Testing Service Market by Company

Eurofins Scientific

SGS

Q2 Solutions

Samsung Biologics

Texcell

WuXi Biologics

Wuhan Canvest Biotechnology

Centre Testing International (CTI)

Suzhou Liangchen Biotechnology

JADE Biomedical

Standard Testing Group

Sino Tech World Biologicals

CAS Testing Technical Services

NTEK

Sino Biological

Miracle Points

Suzhou Cefety Bioscience

Zhejiang Hengyu Biological

Merck

Charles River Laboratories

Sartorius

Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Type

Raw Materials

Viral Banks

Cell Banks

Others

Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Application

Pharmaceutical and Biotechnology Companies

CROs and CDMOs

Academic and Research Institutions

Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical and Biopharmaceutical Safety Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical and Biopharmaceutical Safety Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical and Biopharmaceutical Safety Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Pharmaceutical and Biopharmaceutical Safety Testing Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Region (2021-2026) Table 4. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Region (2027-2032) Table 6. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Share by Type (2021-2026) Table 9. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Share by Application (2021-2026) Table 24. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Trends Table 37. Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Drivers Table 38. Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Opportunities and Challenges Table 39. Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Restraints Table 40. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Company (2021-2026) Table 42. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Key Company Headquarters & Area Served Table 44. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Company, Product Type & Application Table 45. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Pharmaceutical and Biopharmaceutical Safety Testing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Eurofins Scientific Company Information Table 49. Eurofins Scientific Business Overview Table 50. Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 52. Eurofins Scientific Recent Development Table 53. SGS Company Information Table 54. SGS Business Overview Table 55. SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 57. SGS Recent Development Table 58. Q2 Solutions Company Information Table 59. Q2 Solutions Business Overview Table 60. Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 62. Q2 Solutions Recent Development Table 63. Samsung Biologics Company Information Table 64. Samsung Biologics Business Overview Table 65. Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 67. Samsung Biologics Recent Development Table 68. Texcell Company Information Table 69. Texcell Business Overview Table 70. Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 72. Texcell Recent Development Table 73. WuXi Biologics Company Information Table 74. WuXi Biologics Business Overview Table 75. WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 77. WuXi Biologics Recent Development Table 78. Wuhan Canvest Biotechnology Company Information Table 79. Wuhan Canvest Biotechnology Business Overview Table 80. Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 82. Wuhan Canvest Biotechnology Recent Development Table 83. Centre Testing International (CTI) Company Information Table 84. Centre Testing International (CTI) Business Overview Table 85. Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 87. Centre Testing International (CTI) Recent Development Table 88. Suzhou Liangchen Biotechnology Company Information Table 89. Suzhou Liangchen Biotechnology Business Overview Table 90. Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 92. Suzhou Liangchen Biotechnology Recent Development Table 93. JADE Biomedical Company Information Table 94. JADE Biomedical Business Overview Table 95. JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 97. JADE Biomedical Recent Development Table 98. Standard Testing Group Company Information Table 99. Standard Testing Group Business Overview Table 100. Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 102. Standard Testing Group Recent Development Table 103. Sino Tech World Biologicals Company Information Table 104. Sino Tech World Biologicals Business Overview Table 105. Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 107. Sino Tech World Biologicals Recent Development Table 108. CAS Testing Technical Services Company Information Table 109. CAS Testing Technical Services Business Overview Table 110. CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 112. CAS Testing Technical Services Recent Development Table 113. NTEK Company Information Table 114. NTEK Business Overview Table 115. NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 117. NTEK Recent Development Table 118. Sino Biological Company Information Table 119. Sino Biological Business Overview Table 120. Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 122. Sino Biological Recent Development Table 123. Miracle Points Company Information Table 124. Miracle Points Business Overview Table 125. Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 127. Miracle Points Recent Development Table 128. Suzhou Cefety Bioscience Company Information Table 129. Suzhou Cefety Bioscience Business Overview Table 130. Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 132. Suzhou Cefety Bioscience Recent Development Table 133. Zhejiang Hengyu Biological Company Information Table 134. Zhejiang Hengyu Biological Business Overview Table 135. Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 137. Zhejiang Hengyu Biological Recent Development Table 138. Merck Company Information Table 139. Merck Business Overview Table 140. Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 142. Merck Recent Development Table 143. Charles River Laboratories Company Information Table 144. Charles River Laboratories Business Overview Table 145. Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 147. Charles River Laboratories Recent Development Table 148. Sartorius Company Information Table 149. Sartorius Business Overview Table 150. Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 152. Sartorius Recent Development Table 153. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2026) Table 156. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share Forecast by Country (2027-2032) Table 158. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2026) Table 161. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2026) Table 166. Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share Forecast by Country (2027-2032) Table 168. Latin America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2026) Table 171. Latin America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share Forecast by Country (2027-2032) Table 173. Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2026) Table 176. Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share Forecast by Country (2027-2032) Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Pharmaceutical and Biopharmaceutical Safety Testing Service Product Image Figure 3. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Region: 2025 VS 2032 Figure 6. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Region (2021-2032) Figure 7. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Raw Materials Image Figure 13. Global Raw Materials Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Viral Banks Image Figure 15. Global Viral Banks Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Cell Banks Image Figure 17. Global Cell Banks Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Type 2025 VS 2032 Figure 22. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Share by Type (2021-2032) Figure 23. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Share by Type (2021-2032) Figure 25. Latin America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Share by Type (2021-2032) Figure 27. Pharmaceutical and Biotechnology Companies Image Figure 28. Global Pharmaceutical and Biotechnology Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. CROs and CDMOs Image Figure 30. Global CROs and CDMOs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Academic and Research Institutions Image Figure 32. Global Academic and Research Institutions Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Application 2025 VS 2032 Figure 35. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Share by Application (2021-2032) Figure 36. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Share by Application (2021-2032) Figure 38. Latin America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Pharmaceutical and Biopharmaceutical Safety Testing Service Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2032) Figure 45. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2032) Figure 48. Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2032) Figure 51. Latin America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2032) Figure 54. Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Raw Materials
  • Viral Banks
  • Cell Banks
  • Others
Applications
  • Pharmaceutical and Biotechnology Companies
  • CROs and CDMOs
  • Academic and Research Institutions
Companies covered
  • Eurofins Scientific
  • SGS
  • Q2 Solutions
  • Samsung Biologics
  • Texcell
  • WuXi Biologics
  • Wuhan Canvest Biotechnology
  • Centre Testing International (CTI)
  • Suzhou Liangchen Biotechnology
  • JADE Biomedical
  • Standard Testing Group
  • Sino Tech World Biologicals
  • CAS Testing Technical Services
  • NTEK
  • Sino Biological
  • Miracle Points
  • Suzhou Cefety Bioscience
  • Zhejiang Hengyu Biological
  • Merck
  • Charles River Laboratories
  • Sartorius

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032)
  8. 1.5.1 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (2021-2032)
2 Pharmaceutical and Biopharmaceutical Safety Testing Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Raw Materials
  3. 2.1.2 Viral Banks
  4. 2.1.3 Cell Banks
  5. 2.1.4 Others
  6. 2.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type
  7. 2.2.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Regions
  11. 2.3.1 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Type (2021-2026)
3 Pharmaceutical and Biopharmaceutical Safety Testing Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceutical and Biotechnology Companies
  3. 3.1.2 CROs and CDMOs
  4. 3.1.3 Academic and Research Institutions
  5. 3.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application
  6. 3.2.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Regions
  10. 3.3.1 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Trends
  2. 4.2 Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Drivers
  3. 4.3 Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Opportunities and Challenges
  4. 4.4 Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (2021-2026)
  2. 5.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Key Company Headquarters & Area Served
  4. 5.4 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Company, Product Type & Application
  5. 5.5 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Pharmaceutical and Biopharmaceutical Safety Testing Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Pharmaceutical and Biopharmaceutical Safety Testing Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Eurofins Scientific
  2. 6.1.1 Eurofins Scientific Company Information
  3. 6.1.2 Eurofins Scientific Business Overview
  4. 6.1.3 Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  6. 6.1.5 Eurofins Scientific Recent Developments
  7. 6.2 SGS
  8. 6.2.1 SGS Company Information
  9. 6.2.2 SGS Business Overview
  10. 6.2.3 SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  12. 6.2.5 SGS Recent Developments
  13. 6.3 Q2 Solutions
  14. 6.3.1 Q2 Solutions Company Information
  15. 6.3.2 Q2 Solutions Business Overview
  16. 6.3.3 Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  18. 6.3.5 Q2 Solutions Recent Developments
  19. 6.4 Samsung Biologics
  20. 6.4.1 Samsung Biologics Company Information
  21. 6.4.2 Samsung Biologics Business Overview
  22. 6.4.3 Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  24. 6.4.5 Samsung Biologics Recent Developments
  25. 6.5 Texcell
  26. 6.5.1 Texcell Company Information
  27. 6.5.2 Texcell Business Overview
  28. 6.5.3 Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  30. 6.5.5 Texcell Recent Developments
  31. 6.6 WuXi Biologics
  32. 6.6.1 WuXi Biologics Company Information
  33. 6.6.2 WuXi Biologics Business Overview
  34. 6.6.3 WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  36. 6.6.5 WuXi Biologics Recent Developments
  37. 6.7 Wuhan Canvest Biotechnology
  38. 6.7.1 Wuhan Canvest Biotechnology Company Information
  39. 6.7.2 Wuhan Canvest Biotechnology Business Overview
  40. 6.7.3 Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  42. 6.7.5 Wuhan Canvest Biotechnology Recent Developments
  43. 6.8 Centre Testing International (CTI)
  44. 6.8.1 Centre Testing International (CTI) Company Information
  45. 6.8.2 Centre Testing International (CTI) Business Overview
  46. 6.8.3 Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  48. 6.8.5 Centre Testing International (CTI) Recent Developments
  49. 6.9 Suzhou Liangchen Biotechnology
  50. 6.9.1 Suzhou Liangchen Biotechnology Company Information
  51. 6.9.2 Suzhou Liangchen Biotechnology Business Overview
  52. 6.9.3 Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  54. 6.9.5 Suzhou Liangchen Biotechnology Recent Developments
  55. 6.10 JADE Biomedical
  56. 6.10.1 JADE Biomedical Company Information
  57. 6.10.2 JADE Biomedical Business Overview
  58. 6.10.3 JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  60. 6.10.5 JADE Biomedical Recent Developments
  61. 6.11 Standard Testing Group
  62. 6.11.1 Standard Testing Group Company Information
  63. 6.11.2 Standard Testing Group Business Overview
  64. 6.11.3 Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  66. 6.11.5 Standard Testing Group Recent Developments
  67. 6.12 Sino Tech World Biologicals
  68. 6.12.1 Sino Tech World Biologicals Company Information
  69. 6.12.2 Sino Tech World Biologicals Business Overview
  70. 6.12.3 Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  72. 6.12.5 Sino Tech World Biologicals Recent Developments
  73. 6.13 CAS Testing Technical Services
  74. 6.13.1 CAS Testing Technical Services Company Information
  75. 6.13.2 CAS Testing Technical Services Business Overview
  76. 6.13.3 CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  78. 6.13.5 CAS Testing Technical Services Recent Developments
  79. 6.14 NTEK
  80. 6.14.1 NTEK Company Information
  81. 6.14.2 NTEK Business Overview
  82. 6.14.3 NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  84. 6.14.5 NTEK Recent Developments
  85. 6.15 Sino Biological
  86. 6.15.1 Sino Biological Company Information
  87. 6.15.2 Sino Biological Business Overview
  88. 6.15.3 Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  90. 6.15.5 Sino Biological Recent Developments
  91. 6.16 Miracle Points
  92. 6.16.1 Miracle Points Company Information
  93. 6.16.2 Miracle Points Business Overview
  94. 6.16.3 Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  96. 6.16.5 Miracle Points Recent Developments
  97. 6.17 Suzhou Cefety Bioscience
  98. 6.17.1 Suzhou Cefety Bioscience Company Information
  99. 6.17.2 Suzhou Cefety Bioscience Business Overview
  100. 6.17.3 Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  102. 6.17.5 Suzhou Cefety Bioscience Recent Developments
  103. 6.18 Zhejiang Hengyu Biological
  104. 6.18.1 Zhejiang Hengyu Biological Company Information
  105. 6.18.2 Zhejiang Hengyu Biological Business Overview
  106. 6.18.3 Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  108. 6.18.5 Zhejiang Hengyu Biological Recent Developments
  109. 6.19 Merck
  110. 6.19.1 Merck Company Information
  111. 6.19.2 Merck Business Overview
  112. 6.19.3 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  114. 6.19.5 Merck Recent Developments
  115. 6.20 Charles River Laboratories
  116. 6.20.1 Charles River Laboratories Company Information
  117. 6.20.2 Charles River Laboratories Business Overview
  118. 6.20.3 Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  120. 6.20.5 Charles River Laboratories Recent Developments
  121. 6.21 Sartorius
  122. 6.21.1 Sartorius Company Information
  123. 6.21.2 Sartorius Business Overview
  124. 6.21.3 Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  126. 6.21.5 Sartorius Recent Developments
7 North America
  1. 7.1 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026)
  3. 7.3 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026)
  3. 8.3 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026)
  3. 10.3 South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst